Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

Abroad (travel likely)RecruitingPHASE4

Conditions

Hepatitis B · Cirrhosis, Liver · Chronic Liver Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mercy Medical Center, Baltimore, Maryland, United States
Contact: Study coordinator (CHAU TO, MD) · cto@mdmercy.com · 714-400-1331
Contact: Study coordinator (PAUL THULUVATH, MD) · pthuluv@mdmercy.com · (410)-332-9308

Study leads

Paul Thuluvath, MD
Principal Investigator
Mercy Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of Patients With Liver Disease

Hepatitis D · Hepatitis C · Hepatitis B

Abroad (travel likely)Recruiting

Bethesda, United States

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

Carcinoma, Hepatocellular · Hepatitis C, Chronic · Hepatitis B, Chronic

Abroad (travel likely)Recruiting

Shanghai, China

ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis b

Abroad (travel likely)RecruitingPHASE4

Chongqing, China

Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors

Hepatitis B Virus (HBV) · Lung Transplant Recipient

Abroad (travel likely)RecruitingPHASE4

Toronto, Canada